Detection of normal and chimeric nucleophosmin in human cells

Blood

Volumn 93, Issue 2, 1999, Pages 632-642

  Cordell, Jacqueline L ^c   Pulford, Karen A F ^c   Bigerna, Barbara ^c   Roncador, Giovanna ^c   Banham, Alison ^c   Colombo, Emanuela ^c   Pelicci, Pier Giuseppe ^c   Mason, David Y ^a   Falini, Brunangelo ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b POLICLINICO MONTELUCE   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; MONOCLONAL ANTIBODY; NUCLEOPHOSMIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOPLASM; FUSION GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0033556354     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.632     Document Type: Article

References (55)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
2. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol 71:31, 1989
3. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
4. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
5. Bischof D, Pulford K, Mason DY, Morris SW: Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 17:2312, 1997
6. Mason DY, Pulford KAF, Bischof D, Kuefer MU, Butler LH, Lamant L, Delsol G, Morris SW: Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res 58:1057, 1998
7. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW: Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 90:2901, 1997
8. Dragon-Durey MA, Goguel AF, Leonard C, Berger R, Bressac-de-Paillerets B, Fauvet D, Bernheim A: Non-Hodgkin's lymphomas and myeloid disorders: Deletions associated with t(2;5) and t(3;5) detected by FISH. Leukemia 12:1159, 1998
9. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ: The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87:882, 1996
10. Kalantry S, Delva L, Gaboli M, Gandini D, Giorgio M, Hawe N, He LZ, Peruzzi D, Rivi R, Tribioli C, Wang ZG, Zhang H, Pandolfi PP: Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia. J Cell Physiol 173:288, 1997
11. Pandolfi PP: PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia. Haematologica 81:472, 1996
12. Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ, Carroll AJ, Morris SW: The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12:265, 1996
13. Xie J, Briggs JA, Morris SW, Olson MO, Kinney MC, Briggs RC: MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia. Exp Hematol 25:1111, 1997
14. Chan WC: The t(2;5) or NPM-ALK translocation in lymphomas: Diagnostic considerations. Adv Anat Pathol 3:396, 1996
15. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
16. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC: Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 86:3517, 1995
17. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC: Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23; q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 345:87, 1995
18. Orscheschek K, Merz H, Hell J, Feller AC: Presence of the t(2;5) in Hodgkin's disease. Blood 86:4383, 1995
19. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9:1567, 1994
20. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84: 3648, 1994
21. Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY: Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALKI. Blood 89:1394, 1997
22. Falini B, Bigerna B, Fizzotti M, Pulford K, Pileri SA, Delsol G, Carbone A, Paulli M, Magrini U, Menestrina F, Giardini R, Pilotti S, Mezzelani A, Ugolini B, Billi M, Pucciarini A, Pacini R, Pelicci P-G, Flenghi L: ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol 153:875, 1998
23. Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S: Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995
24. Pileri SA, Pulford K, Mori S, Mason DY, Sabattini E, Roncador G, Piccioli M, Ceccarelli C, Piccaluga PP, Santini D, Leone O, Stein H, Falini B: Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. Am J Pathol 150:1207, 1997
25. Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C: The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 151:343, 1997
26. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugières L, Terrier-Lacombe M-J, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G: ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 91:2076, 1998
27. Delsol G, Lamant L, Mariamé B, Pulford K, Dastugue N, Brousset P, Rigal HF, Al Saati T, Cerretti DP, Morris SW, Mason DY: A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 89:1483, 1997
28. Lamant L, Meggetto F, Al Saati T, Brugières L, de Paillerets BB, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87:284, 1996
29. Sainati L, Montaldi A, Stella A, Putti MC, Zanesco L, Basso G: A novel variant translocation t(2;13)(p23;q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol 75:621, 1990
30. Wlodarska I, De Wolf Peeters C, Machaux L, Mecucci C, Verhoef G, Cassiman JJ, Van den Berghe H: A new t(2;5) translocation in a null cell type CD30 positive anaplastic large cell lymphoma case. Leukemia 9:1685, 1995
31. Tone LG, Defavery R, Scrideli CA, Bernardes JE, Torres FM, Soares FA, Peres LC, Duarte MH: Translocation (1;5)(q32;q35) in CD30+ anaplastic large cell non-Hodgkin lymphoma of childhood - A case report. Cancer Genet Cytogenet 86:83, 1996
32. Mitev L, Christova S, Hadjiev E, Guenova M, Oucheva R, Valkov I, Manolova Y: A new variant chromosomal translocation t(2;2)(p23;q23) in CD30+/Ki-1+ anaplastic large cell lymphoma. Leuk Lymphoma 28:613, 1998
33. Erber WN, Pinching AJ, Mason DY: Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1:1042, 1984
34. Harlow E, Lane D: Immunizations, in Antibodies. A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988, p 90
35. Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG: Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J 15:4949, 1996
36. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
37. Mason DY, Cordell JL, Pulford KAF: Production of monoclonal antibodies for immunocytochemical use, in Bullock GR, Petrusz P (eds): Techniques in Immunocytochemistry. New York, NY, Academic, 1983, p 175
38. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye BH, Gambacorta M, Pacini R, Baroni C, Pescarmona E, Anagnostopoulos I, Stein H, Asdrubali G, Martelli MF, Pelicci PG, Dalla Pavera R, Falini B: Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 148:1543, 1996
39. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
40. Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B: Antigen retrieval techniques in immunohistochemistry: Comparison of different methods. J Pathol 183:116, 1997
41. Michalik J, Yeoman LC, Busch H: Nucleolar localization of protein B23 (37/5.1) by immunocytochemical techniques. Life Sci 28:1371, 1981
42. Feuerstein N, Chan PK, Mond JJ: Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem 263:10608, 1988
43. Biggiogera M, Fakan S, Kaufmann SH, Black A, Shaper JH, Busch H: Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus. J Histochem Cytochem 37:1371, 1989
44. Ochs R, Lischwe M, O'Leary P, Busch H: Localization of nucleolar phosphoproteins B23 and C23 during mitosis. Exp Cell Res 146:139, 1983
45. Chan PK, Aldrich MB, Chakrabarty S: Assessment of tumor cell sensitivity to mitomycin C by "B23 translocation" assay. Cancer Lett 40:143, 1988
46. Yung BY, Bor AM, Yang YH: Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HeLa cells. Int J Cancer 46:272, 1990
47. Chan PK: Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). Exp Cell Res 203:174, 1992
48. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379, 1989
49. Lu YY, Lam CY, Yung BY: Decreased accumulation and dephosphorylation of the mitosis-specific form of nucleophosmin/B23 in staurosporine-induced chromosome decondensation. Biochem J 317:321, 1996
50. Bocker T, Bittinger A, Wieland W, Buettner R, Fauser G, Hofstaedter F, Ruschoff J: In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate. Mod Pathol 8:226, 1995
51. Nozawa Y, Van Beizen N, Van der Made AC, Dinjens WN, Bosman FT: Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 178:48, 1996
52. Wu MH, Lam CY, Yung BY: Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP. Biochem J 305:987, 1995
53. Zatsepina OV, Todorov IT, Philipova RN, Krachmarov CP, Trendelenburg MF, Jordan EG: Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants. Eur J Cell Biol 73:58, 1997
54. Chan PK, Liu QR, Durban E: The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II. Biochem J 270:549, 1990
55. Peter M, Nakagawa J, Doree M, Labbe JC, Nigg EA: Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60:791, 1990